Innate and adaptive immunity: Specificities and signaling hierarchies revisited

Nature Immunology

Volumn 6, Issue 1, 2005, Pages 17-21

  Vivier, Eric ^a   Malissen, Bernard ^a  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR;

CELLULAR IMMUNITY; CLASSIFICATION; CLONAL VARIATION; CROSS REACTION; GERM LINE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MITOTIC RECOMBINATION; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGEN-PRESENTING CELLS; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, NATURAL; SIGNAL TRANSDUCTION;

EID: 12344335678     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1153     Document Type: Review

References (61)

1. Janeway, C.A., Jr. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002).
2. Beutler, B. Not "molecular patterns" but molecules. Immunity 19, 155-158 (2003).
3. Beutler, B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430, 257-263 (2004).
4. Raulet, D.H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat. Immunol. 5, 996-1002 (2004).
5. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C.A., Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397 (1997).
6. Pancer, Z. et al. Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey. Nature 430, 174-180 (2004).
7. Rudolph, M.G. & Wilson, I.A. The specificity of TCR/pMHC interaction. Curr. Opin. Immunol. 14, 52-65 (2002).
8. Cancro, M.P. & Kearney, J.F. B cell positive selection: road map to the primary repertoire? J. Immunol. 173, 15-19 (2004).
9. Crozat, K. & Beutler, B. TLR7: a new sensor of viral infection. Proc. Natl. Acad. Sci. USA 101, 6835-6836 (2004 ).
10. Wedemayer, G.J., Patten, P.A., Wang, L.H., Schultz, P.G. & Stevens, R.C. Structural insights into the evolution of an antibody combining site. Science 276, 1665-1669 (1997).
11. Mason, D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19, 395-404 (1998).
12. Goldrath, A.W. & Bevan, M.J. Selecting and maintaining a diverse T-cell repertoire. Nature 402, 255-262 (1999).
13. 8+ T cells in lymphopenic hosts. Immunity 11, 183-190 (1999).
14. Selin, L.K. et al. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 11, 733-742 (1999).
15. Welsh, R.M., Selin, L.K. & Szomolanyi-Tsuda, E. Immunological memory to viral infections. Annu. Rev. Immunol. 22, 711-743 (2004).
16. Weis, W.I., Taylor, M.E. & Drickamer, K. The C-type lectin superfamily in the immune system. Immunol. Rev. 163, 19-34 (1998).
17. Weis, W.I. & Drickamer, K. Trimeric structure of a C-type mannose-binding protein. Structure 2, 1227-1240 (1994).
18. Sheriff, S., Chang, C.Y. & Ezekowitz, R.A. Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple α-helical coiled-coil. Nat. Struct. Biol. 1 789-794 (1994).
19. Ulevitch, R.J. Therapeutics targeting the innate immune system. Nat. Rev. Immunol. 4, 512-520 (2004).
20. Girardin, S.E. et al. Nod1 detects a unique muropepticle from Gram-negative bacterial peptidoglycan. Science 300, 1584-1587 (2003).
21. Smith, H.R. et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99, 8826-8831 (2002).
22. Arase, H., Mocarski, E.S., Campbell, A.E., Hill, A.B. & Lanier, L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323-1326 (2002 ).
23. Vivier, E. & Biron, C.A. A pathogen receptor on natural killer cells. Science 296, 1248-1249 (2002).
24. Maenaka, K. et al. Killer cell immunoglobulin receptors and T cell receptors bind peptice-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J. Biol. Chem. 274, 28329-28334 (1999).
25. Zinkernagel, R.M. Uncertainties- discrepancies in immunology. Immunol. Rev. 185, 103-125 (2002).
26. Stefanova, I. et al. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat Immunol. 4, 248-254 (2003).
27. 3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation. J. Biol. Chem. 278, 26983-26991 (2003).
28. Berg, R.E., Crossley, E., Murray, S. & Forman, J. Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J. Exp. Med. 198, 1583-1593 (2003).
29. Bernasconi, N.L., Onai, N. & Lanzavecchia, A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101, 4500-4504 (2003).
30. Weiss, A. & Littman, D.R. Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274 (1994).
31. Vély, F. & Vivier, E. Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and non-inhibitory/activatory counterparts. J. Immunol. 159, 2075-2077 (1997).
32. Long, E.O. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17, 875-904 (1999).
33. Ravetch, J.V. & Lanier, L.L. Immune inhibitory receptors. Science 290, 84-89 (2000).
34. Renard, V. et al. Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Immunol. Rev. 155, 205-221 (1997).
35. Vivier, E. & Anfossi, N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat. Rev. Immunol. 4, 190-198 (2004).
36. Bendelac, A., Bonneville, M. & Kearney, J.F. Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. 1, 177-186 (2001).
37. Vivier, E., Tomasello, E. & Paul, P. Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Curr. Opin. Immunol. 14, 306-311 (2002).
38. Raulet, D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3, 781-790 (2003).
39. Groh, V., Bruhl, A., El-Gabalawy, H., Nelson, J.L. & Spies, T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 100, 9452-9457 (2003).
40. Poe, J.C., Hasegawa, M. & Tedder, T.F. CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction. Int. Rev. Immunol. 20, 739-762 (2001).
41. Dal Porto, J.M. et al. B cell antigen receptor signaling 101. Mol. Immunol. 41, 599-613 (2004).
42. Daeron, M. et al. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR, and FcR-dependent cell activation. Immunity 3, 635-646 (1995).
43. Karre, K., Ljunggren, H.G., Piontek, G. & Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675-678 (1986).
44. Diefenbach, A., Jensen, E.R., Jamieson, A.M. & Raulet, D.H. Rael and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413, 165-171 (2001).
45. Cerwenka, A., Baron, J.L. & Lanier, L.L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 98, 11521-11526 (2001).
46. Bouchon, A., Dietrich, J. & Colonna, M. Cutting edge: inflammatory responses can Be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 164, 4991-4995 (2000).
47. Bouchon, A., Facchetti, F., Weigand, M.A. & Colonna, M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410, 1103-1107 (2001).
48. Orwell, G. Animal Farm (Secker and Warburg, London, 1945).
49. den Haan, J.M.M. et al. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 268, 1476-1480 (1995).
50. Housset, D. & Malissen, B. What do TCR-pMHC crystal structures teach us about MHC restriction and alloreactivity? Trends Immunol. 24, 429-437 (2003).
51. Ruggeri, L. et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295, 2097-2100 (2002).
52. Zinkernagel, R.M. & Doherty, P. Immunological surveillance against altered self components by sensitized T lymphocytes in lymphochoriomeningitis. Nature 251, 547-552 (1974).
53. Moretta, L. et al. Human natural killer cells: their origin, receptors and function. Eur J. Immunol. 32, 1205-1211 (2002).
54. Iizuka, K., Naidenko, O.V., Plougastel, B.F., Fremont, D.H. & Yokoyama, W.M. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat. Immunol. 801-807 (2003).
55. Carlyle, J.R. et al. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc. Natl. Acad. Sci. USA 101, 3527-3532 (2004).
56. Reiser, J.B. et al. CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat. Immunol. 4, 241-247 (2003).
57. Malissen, B. An evolutionary and structural perspective on T cell antigen receptor function. Immunol. Rev. 191, 7-27 (2003).
58. Colonna, M. TREMs in the immune system and beyond. Nat. Rev. Immunol. 3, 445-453 (2003).
59. Olcese, L. et al. Killer-cell activatory receptors for MHC Class I molecules are included in a multimeric complex expressed by human killer cells. J. Immunol. 158, 5083-5086 (1997).
60. Lanier, L.L., Corliss, B.C., Wu, J., Leong, C. & Phillips, J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391, 703-707 (1998 ).
61. Aoki, N. et al. The role of the DAP12 signal in mouse myeloid differentiation. J. Immunol. 165, 3790-3796 (2000).